Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Anticonvulsants (Find 20 items)

Sort Anticonvulsants Alphabetically

Anticonvulsants

Control seizures effectively with high-quality anticonvulsant raw materials. Explore a wide range of anticonvulsant chemical products with CAS NO., property data, and SDS. Purchase raw materials from certified suppliers to support pharmaceutical formulations and neurological research.

Licarbazepine

(29331-92-8)
10,11-dihydro-10-hydroxy Carbamazepinee is the active metabolite of oxcarbazepine . Oxcarbazepine is rapidly and almost completely converted to 10,11-dihydro-10-hydroxycarbamazepine, which then demonstrates anticonvulsant efficacy by modulating several ion channels and receptors. ?10,11-dihydro-10-hydroxy Carbamazepine is reported to inhibit both voltage-gated Na+ and Ca2+ channels, to potentiate voltage-gated K+ channels, to antagonize adenosine A1 receptors, to increase dopaminergic transmissi

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Methyl 2-(4-(hydroxymethyl)phenyl)acetate

(155380-11-3)

Product List

Request for quotation , get quotes from more suppliers.

(R)-N-((S)-1-Amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide

(2242647-55-6)

Request for quotation , get quotes from more suppliers.

  • 1
  • 2
  • Go to Page Go
Anticonvulsants Intermediates are some key chemical raw materials or products in the synthesis process of anticonvulsant drugs. You can easily find high-quality new anticonvulsants intermediates, products and their manufacturers or suppliers on ECHEMI. We will continue to track the research and development of new products on anticonvulsant medicine.

More Information

Anticonvulsants, also known as anti-seizure or anti-epileptic agents, are substances used to prevent or reduce the frequency and severity of seizures. They are widely applied in the treatment of epilepsy, neuropathic pain, and certain psychiatric disorders, making them essential in modern neurology and pharmaceutical development.

Key mechanisms of action for anticonvulsants include:
• Stabilizing neuronal membranes by blocking sodium or calcium ion channels, reducing abnormal electrical activity in the brain.
• Enhancing the activity of inhibitory neurotransmitters such as GABA, helping to suppress seizure activity.
• Reducing excitatory neurotransmitter release, thereby lowering the risk of overactive neuronal firing.

Factors to consider when selecting anticonvulsant raw materials:
• Spectrum of activity – some agents are effective for generalized seizures, while others target focal or partial seizures.
• Safety and tolerability – side effect profile, drug interactions, and patient compliance are critical.
• Formulation requirements – solubility, stability, and compatibility with excipients in tablets, capsules, or injectable solutions.
• Regulatory compliance – adherence to pharmaceutical safety and manufacturing standards.

Common anticonvulsant raw materials include carbamazepine, valproic acid, lamotrigine, and gabapentin. They are typically supplied in crystalline or powder forms for use in oral solid dosage forms, solutions, or controlled-release formulations. These agents are not only vital in epilepsy management but also increasingly used in treating neuropathic pain and bipolar disorder.

Frequently Asked Questions

What are anticonvulsants and how do they work?

Anticonvulsants, also known as antiepileptic drugs (AEDs), are medications used to prevent or reduce the frequency and severity of seizures in conditions like epilepsy. They work by stabilizing electrical activity in the brain, often through mechanisms such as enhancing GABA inhibition, blocking sodium or calcium channels, or modulating glutamate activity. Understanding their mechanism helps clinicians choose the most appropriate therapy for specific seizure types.

What are the common types of anticonvulsant medications?

Common anticonvulsant medications include older-generation drugs like phenytoin, valproic acid, and carbamazepine, as well as newer agents such as levetiracetam, lamotrigine, and topiramate. Each class has distinct pharmacokinetics, side effect profiles, and indications—ranging from focal and generalized seizures to mood stabilization or neuropathic pain management. Choosing the right type depends on the patient’s diagnosis, age, comorbidities, and potential drug interactions.

What are the potential side effects of anticonvulsants?

Anticonvulsants can cause a range of side effects, including drowsiness, dizziness, nausea, weight changes, and cognitive impairment. Some may lead to serious reactions like Stevens-Johnson syndrome (e.g., with lamotrigine or carbamazepine) or hepatotoxicity (e.g., with valproic acid). Regular monitoring of blood levels, liver function, and skin reactions is essential, especially during treatment initiation or dose adjustments.

How are anticonvulsants used beyond epilepsy treatment?

Beyond epilepsy, anticonvulsants are commonly prescribed for off-label uses such as bipolar disorder (e.g., valproate, lamotrigine), neuropathic pain (e.g., gabapentin, pregabalin), and migraine prophylaxis (e.g., topiramate). Their ability to modulate neuronal excitability makes them effective in various neurological and psychiatric conditions. However, use should always be guided by clinical evidence and professional medical advice.

What factors should be considered when selecting an anticonvulsant for a patient?

Selecting an appropriate anticonvulsant involves evaluating several key factors: the type of seizure or condition being treated, the patient’s age and gender (e.g., teratogenic risks in women of childbearing age), comorbid medical conditions, potential drug interactions, side effect profile, dosing convenience, and cost. Therapeutic drug monitoring may also be necessary for certain anticonvulsants to ensure efficacy and safety.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.